BRIEVRE, created in 2014 (United States), from 19 sister brands and 2214 competing brands. BRIEVRE is owned by Biomarin Pharmaceutical, listed on the stock exchange of New York BRIEVRE is part of the Biotechnology activity sector.
Buy Biomarin Pharmaceutical share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
